A 28-year-old software engineer in Bengaluru, slim and active, is told he has diabetes. The doctor starts metformin, but six months later his sugars are still climbing and he has lost five kilos without trying. Is this type 2 diabetes that needs stronger tablets, or something else? The single test that often answers that question costs less than a pizza: the C-peptide test.
India has more than 10 crore people with diabetes, according to the ICMR-INDIAB study, and Indians tend to develop it younger and at a lower body weight than people in many other countries. That makes it harder to tell the types of diabetes apart just by looking at someone. The C-peptide test shows how much insulin your own pancreas is still making, and that one fact can change your treatment, sometimes from daily injections to tablets, or the other way round. This guide explains what C-peptide is, the C-peptide normal range, how doctors use it to classify diabetes, and how to prepare for the test.
What Is C-Peptide?
Your pancreas makes insulin in its beta cells, first as a larger molecule called proinsulin. Just before release, proinsulin is split into two pieces: insulin and C-peptide (connecting peptide). Both are released into the blood in equal amounts.
That makes C-peptide a near-perfect marker of how much insulin your body is producing on its own:
- C-peptide lasts longer in the blood (around 30 minutes, against about 5 minutes for insulin), so levels are steadier and easier to measure.
- Injected insulin does not contain C-peptide. So even if you are on insulin injections, the C-peptide test still shows how much insulin your own pancreas makes.
- The liver removes much of the insulin before it reaches the rest of the body, but not C-peptide. C-peptide is cleared mainly by the kidneys.
In short: insulin tells you what is circulating; C-peptide tells you what your pancreas is producing.
Why Doctors Order a C-Peptide Test
1. To tell type 1 from type 2 diabetes
This is the most common reason. In type 1 diabetes, the immune system destroys the beta cells, so C-peptide becomes very low or undetectable. In type 2 diabetes, the pancreas usually still makes plenty of insulin, at least in the early years, but the body does not respond to it well (insulin resistance). C-peptide is often normal or even high.
Getting this right matters. A person with type 1 diabetes who is wrongly treated with tablets alone can slip into diabetic ketoacidosis (DKA), a medical emergency. Read more in our type 1 diabetes guide.
2. To identify less common types of diabetes
- LADA (latent autoimmune diabetes in adults): Sometimes called "type 1.5". It starts in adulthood, looks like type 2 at first, but is autoimmune and gradually needs insulin. C-peptide falls over months to years.
- MODY (maturity-onset diabetes of the young): A genetic form that runs strongly in families across generations. C-peptide stays preserved, and some types respond very well to low-dose sulfonylurea tablets instead of insulin.
- Fibrocalculous pancreatic diabetes (FCPD): A form of diabetes caused by chronic pancreatitis with pancreatic stones, described especially in southern and eastern India. C-peptide is often low.
- Diabetes after pancreatitis or pancreatic surgery (sometimes called type 3c). See our pancreatitis guide.
3. To decide whether insulin can be reduced or stopped
Many Indians with type 2 diabetes are started on insulin during a hospital admission or when sugars are very high. Once things settle, C-peptide helps your doctor decide whether you could switch back to tablets or newer medicines, or whether your own insulin production has fallen too low.
4. To investigate low blood sugar (hypoglycaemia)
When someone without diabetes has repeated low sugars, measuring insulin and C-peptide during a hypoglycaemic episode helps find the cause:
| Finding during low sugar | Likely explanation |
|---|---|
| High insulin, high C-peptide | The body is making too much insulin: an insulinoma (a rare pancreatic tumour) or sulfonylurea tablets |
| High insulin, low C-peptide | Insulin is coming from injections, not the pancreas |
| Low insulin, low C-peptide | Not caused by insulin; other causes such as liver disease, hormone deficiency or alcohol |
5. Other uses
- Monitoring after pancreas or islet transplantation
- Research and assessment of insulin resistance, though fasting insulin and HOMA-IR are more commonly used for this (see our insulin resistance guide)
C-Peptide Normal Range and Units
Labs report C-peptide in either ng/mL or nmol/L (sometimes pmol/L). Ranges vary between labs, so check the range printed on your report.
| Measure | Typical reference range |
|---|---|
| Fasting C-peptide | About 0.5 – 2.0 ng/mL (some Indian labs use 0.8 – 3.1 ng/mL) |
| Post-meal (stimulated) C-peptide | Usually 2 to 5 times higher than fasting |
Converting units
- ng/mL × 0.331 = nmol/L
- nmol/L × 1,000 = pmol/L
- Example: 1.8 ng/mL ≈ 0.6 nmol/L ≈ 600 pmol/L
If you have reports from two different labs, check the units before comparing them; a jump from "1.5" to "500" may simply be ng/mL versus pmol/L.
How Doctors Interpret C-Peptide in Diabetes
There is no single cut-off that perfectly separates every type of diabetes, but international guidance (widely used by Indian diabetologists) uses these approximate thresholds, usually on a random or post-meal sample taken with a blood glucose test:
| C-peptide level | What it suggests |
|---|---|
| Below 0.2 nmol/L (about 0.6 ng/mL) | Severe insulin deficiency; consistent with type 1 diabetes. Insulin treatment is essential. |
| 0.2 – 0.6 nmol/L (about 0.6 – 1.8 ng/mL) | Intermediate. Can be seen in early type 1 (honeymoon phase), LADA, MODY or long-standing type 2. Antibody tests and clinical judgement are needed. |
| Above 0.6 nmol/L (about 1.8 ng/mL) | Significant insulin production; more consistent with type 2 diabetes or MODY. |
Important rules for interpretation
- Glucose must be measured at the same time. A low C-peptide is only meaningful if blood sugar is not low. If sugar is very low, the pancreas is supposed to switch off, so C-peptide falls naturally.
- Timing after diagnosis matters. In the first months after type 1 diabetes is diagnosed, the honeymoon phase can keep C-peptide in the intermediate range. Testing is most informative three or more years after diagnosis, though doctors may test earlier if there is doubt.
- Kidney disease raises C-peptide, because the kidneys clear it. In people with chronic kidney disease, results can be misleadingly high.
- Very high sugars can temporarily suppress insulin production (called glucotoxicity). C-peptide may rise again once sugars are controlled, so your doctor may repeat the test.
Pairing C-peptide with antibody tests
To confirm autoimmune diabetes (type 1 or LADA), doctors often order pancreatic autoantibodies along with C-peptide:
- GAD65 antibodies (the most common and useful)
- IA-2 antibodies
- ZnT8 antibodies
Positive antibodies with low or falling C-peptide point strongly toward type 1 or LADA. Negative antibodies with preserved C-peptide in a young person with a strong family history may prompt genetic testing for MODY.
C-Peptide and the Indian Diabetes Picture
Indian researchers have shown that diabetes in India does not always look like the "classic" Western type 2 picture.
- The "thin-fat" Indian: Indians tend to carry more body fat, especially around the waist, at the same BMI as Western populations. So a person who looks slim may still have significant insulin resistance with high C-peptide.
- Severe insulin-deficient diabetes: Studies of Indian patients have found that a substantial share of people labelled as type 2 actually have low insulin secretion rather than mainly insulin resistance. These patients tend to be leaner, diagnosed younger, and have higher HbA1c, and they often need insulin earlier. C-peptide helps identify them.
- Young-onset diabetes: With diabetes increasingly diagnosed in people in their 20s and 30s, C-peptide and antibodies help separate type 1, LADA, MODY and early type 2, which all need different treatment.
If you have been diagnosed young, are lean, are losing weight despite treatment, or have a strong family history across three generations, it is reasonable to ask your doctor whether a C-peptide test would help. Our diabetes management guide covers treatment options in detail.
Preparing for the C-Peptide Test in India
Before the test
- Fasting: Most labs ask for 8 to 10 hours of fasting for a fasting C-peptide. Water is allowed.
- Stimulated test: Some doctors want a post-meal C-peptide, taken about 90 minutes to 2 hours after a normal meal, or after a standard liquid meal or glucagon injection in a hospital setting.
- Continue your usual medicines unless your doctor tells you otherwise, but tell the lab about insulin, sulfonylureas (such as glimepiride or gliclazide) and any recent hypoglycaemia.
- Ask for a glucose test on the same sample, if your doctor has not already ordered one.
- Mention biotin supplements, which can interfere with some immunoassays.
Cost and availability
- C-peptide (fasting or PP): roughly ₹500 to ₹1,200 at major lab chains in India
- GAD65 antibodies: typically ₹1,500 to ₹3,000
- Urine C-peptide/creatinine ratio: available at fewer labs; ask your diabetologist
- Most results come within 1 to 2 days, and home sample collection is widely available
Other tests usually ordered alongside
- HbA1c and fasting and post-meal blood sugar
- Kidney function tests and urine microalbumin
- Lipid profile and thyroid tests
- Pancreatic antibodies when autoimmune diabetes is suspected
Keeping Your Diabetes Records Together
Diabetes classification is not always settled at the first visit. Your doctor may compare C-peptide from the time of diagnosis with a repeat test a year or two later, alongside your HbA1c, weight and medication changes. Those reports are often scattered across different labs, hospitals and phone galleries, and an old C-peptide value can be impossible to find just when a new diabetologist asks for it.
When you upload your reports to MedicalVault, your C-peptide, HbA1c, fasting glucose and kidney function values are extracted automatically with their units and reference ranges. MedicalVault's trend analysis shows how your sugars and insulin production have changed over time, which is exactly the history a doctor needs before deciding to start, stop or adjust insulin. If diabetes runs in your family, the family sharing feature helps you keep parents' and siblings' records together too, which is useful when MODY or type 1 is being considered.
Key Takeaways
- The C-peptide test measures how much insulin your own pancreas is producing, even if you inject insulin.
- A typical C-peptide normal range for fasting samples is about 0.5–2.0 ng/mL, but ranges and units (ng/mL vs nmol/L) differ between labs.
- Very low C-peptide (below about 0.6 ng/mL or 0.2 nmol/L) suggests type 1 diabetes and a definite need for insulin; preserved or high C-peptide suggests type 2 or MODY.
- Always interpret C-peptide with a simultaneous blood glucose, and remember that kidney disease and very high sugars can distort results.
- Pairing C-peptide with GAD65 and other antibodies helps identify type 1 diabetes and LADA in adults.
- Indians often develop diabetes young and lean, which makes the C-peptide test especially useful in India.
- Keep your C-peptide, HbA1c and related reports together in MedicalVault so your doctor can see how your insulin production changes over time.